Biotage AB 

€15.89
5
-€0.33-2.03% Wednesday 06:25

统计数据

当日最高
15.89
当日最低
15.89
52周最高
-
52周最低
-
成交量
0
平均成交量
-
市值
1.32B
市盈率
58.29
股息收益率
0.84%
股息
0.13

即将到来

股息

0.84%股息收益率
10年增长
4.91%
5年增长
-1.13%
3年增长
-6.04%
1年增长
-4.02%

收益

23Oct预期
Q1 2024
Q2 2024
下一个
0.05
0.05
0.05
0.06
预期每股收益
0.058491774579206006
实际每股收益
N/A

人们还关注

此列表基于关注PQX1.F的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

关于

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, diagnostics, clinical, environmental protection, food safety, clinical, forensic, and academic laboratories industries. It operates in more than 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.
Show more...
首席执行官
Mr. Andrew Kellett
员工
667
国家
SE
ISIN
SE0000454746
WKN
000A0MNB5

上市公司